Patients with atrial fibrillation who use diltiazem combined with apixaban or rivaroxaban face an increased risk for serious bleeding events compared with those who use metoprolol.
Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding ...
A-Fib Drug Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding By Dennis Thompson HealthDay ReporterTUESDAY, March 3, 2026 (HealthDay News) — People with abnormal heart rhythms ...
A new study has found that some older adults with a common heart rhythm problem may face a higher risk of serious bleeding ...
Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial Receive the the ...
The UAB Cardiothoracic Surgery research team has co-authored a study published in Annals of Thoracic Surgery Short Reports, titled "Oral Diltiazem Prophylaxis for Atrial Fibrillation in Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results